Access and Delivery Advisory Committee (ADAC)

The function of the Access and Delivery Advisory Committee (ADAC) is to advise MMV's Access and Delivery team on appropriate strategies to achieve MMV access and delivery goals.

The ADAC is composed of 10 to 20 members, nominated by the President and CEO. Members are appointed for 2 to 4 years, with appointments staggered so as to provide a rotating membership.

The members of the ADAC come from both industry and academia and cover the full range of expertise required to achieve access objectives.

ADAC Members

Prof Christian Lengeler, Head, Health Interventions Unit, Swiss Tropical and Public Health Institute, Chairman of MMV ADAC

Dr Neena Valecha, Director, National Institute of Malaria Research (NIMR), Indian Council of Medical Research (ICMR), India, Vice Chairman of MMV ADAC

Ms Valentina Buj, Health Specialist (Malaria Partnerships), UNICEF

Dr Elizabeth Chizema, Head of Research at the Ministry of Health, Zambia

Dr Alexander Dodoo, Head of the Centre for Tropical Clinical Pharmacology & Therapeutics (CTCPT), Ghana

Dr Gunther Faber, Chairman One Family Health

Dr Douglas Lungu, Hospital Director of Daeyang Luke Hospital, Malawi

Dr David McGibney, Pharmaceutical research and development expert; Consultant Pharmaceutical Physician; and Co-Chairman MMV ESAC (Development)

Prof Ric Price, Associative Professor at Menzies School of Health Research, Darwin

Dr Brenda Waning, Coordinator of Market Dynamics at UNITAID

Prof. Prashant Yadav, Senior Research Fellow, Healthcare Supply Chains, Director of Healthcare Research Initiative, William Davidson Institute, University of Michigan

Dr Hashim Yusufu, Deputy Director, National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria